IWH Competitors

The Max Planck Institute for Demographic Research (MPIDR) in Rostock is one of the leading demographic research centers in the world. At the MPIDR, researchers from all over the world investigate mortality, fertility, migration and other issues at the forefront of population research. The Institute is headed by its directors Mikko Myrskylä and Emilio Zagheni. The MPIDR is part of the Max Planck Society, the internationally renowned German research society.

As the largest Fraunhofer Institute, Fraunhofer Institute for Integrated Circuits IIS, headquartered in Erlangen, is a global leader in applied research, driving innovation for transformative products and services that shape the digital future. Fraunhofer IIS gained international recognition for developing the mp3 format and next-generation codecs. Today, it is the largest and most economically successful institute within the Fraunhofer-Gesellschaft. Boosting economic competitiveness and contributing to a sustainable future for society – these are the goals by which the institute defines its success. Across seven research divisions, Fraunhofer IIS develops forward-thinking solutions that drive technological progress for its national and international partners and clients in industry, business and the public sector. Its strong performance is built on four core areas of expertise: artificial intelligence, microelectronics, data acquisition and analysis, as well as signal processing and data transmission. Its ability to combine and tailor these competencies to meet the specific needs of industry enables Fraunhofer IIS to provide original and forward-looking solutions to its clients. More than 1,200 employees work in contract research for industry, service providers, and the public sector. Founded in 1985, the institute operates across its locations in 12 cities: Erlangen (headquarters), Nuremberg, Fürth, and Dresden, as well as Bamberg, Deggendorf, Ilmenau, Munich, Passau, Merkendorf, Waischenfeld, and Würzburg. In 2024, Fraunhofer IIS generated €240 million in funding, with 42 percent of its budget covered by revenue from industry. Additional funding came from public projects, institutional funding from the Fraunhofer-Gesellschaft, and other sources.

Official LinkedIn company profile of Heidelberg University Hospital. Heidelberg University Hospital is one of the most important medical centers in Germany; the Heidelberg Medical Faculty of Heidelberg University is one of the internationally renowned biomedical research institutions in Europe. The common goal is the development of innovative diagnostics and therapies and their rapid implementation for patients. The hospital and faculty employ around 13,700 staff and are committed to training and qualification. In more than 50 clinical departments with almost 2,000 beds, approximately 80,000 patients are treated annually as full and partial inpatients and more than 1,000,000 patients are treated as outpatients. Together with the German Cancer Research Center (DKFZ) and German Cancer Aid, Heidelberg University Hospital has established the National Center for Tumor Diseases (NCT) Heidelberg, the leading oncological center of excellence in Germany. In addition, Heidelberg University Hospital, together with the DKFZ and Heidelberg University, operates the Hopp Children's Tumor Center (KiTZ), a therapy and research center for oncological and hematological diseases in childhood and adolescence that is unique in Germany. The Heidelberg Curriculum Medicinale (HeiCuMed) is at the forefront of medical training programs in Germany. Currently, around 3,500 future doctors are studying for their degrees and doctorates at the Heidelberg Medical Faculty.